These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2753 related articles for article (PubMed ID: 17482300)
1. Evidence-based radiation oncology in head and neck squamous cell carcinoma. Corvò R Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300 [TBL] [Abstract][Full Text] [Related]
2. Altered radiation therapy fractionation, chemoradiation, and patient selection for the treatment of head and neck squamous carcinoma. Rosenthal DI; Ang KK Semin Radiat Oncol; 2004 Apr; 14(2):153-66. PubMed ID: 15095261 [TBL] [Abstract][Full Text] [Related]
3. Radiotherapy and chemotherapy in locally advanced head and neck squamous cell carcinoma. Krstevska V J BUON; 2009; 14(3):361-73. PubMed ID: 19810125 [TBL] [Abstract][Full Text] [Related]
5. A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck. Budach W; Hehr T; Budach V; Belka C; Dietz K BMC Cancer; 2006 Jan; 6():28. PubMed ID: 16448551 [TBL] [Abstract][Full Text] [Related]
6. Head and neck squamous cell carcinoma: optimizing the therapeutic index. Rosenthal DI; Blanco AI Expert Rev Anticancer Ther; 2005 Jun; 5(3):501-14. PubMed ID: 16001957 [TBL] [Abstract][Full Text] [Related]
7. Chemoradiation after surgery for high-risk head and neck cancer patients: how strong is the evidence? Bernier J; Cooper JS Oncologist; 2005 Mar; 10(3):215-24. PubMed ID: 15793225 [TBL] [Abstract][Full Text] [Related]
8. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience. Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834 [TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma. Finnegan V; Parsons JT; Greene BD; Sharma V Head Neck; 2009 Feb; 31(2):167-74. PubMed ID: 18853443 [TBL] [Abstract][Full Text] [Related]
10. Adjuvant chemo- and radiotherapy for poor prognosis head and neck squamous cell carcinomas. Bernier J; Pfister DG; Cooper JS Crit Rev Oncol Hematol; 2005 Dec; 56(3):353-64. PubMed ID: 15979887 [TBL] [Abstract][Full Text] [Related]
11. Can concomitant-boost accelerated radiotherapy be adopted as routine treatment for head-and-neck cancers? A 10-year single-institution experience. Allal AS; Taussky D; Mach N; Becker M; Bieri S; Dulguerov P Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1431-6. PubMed ID: 15050320 [TBL] [Abstract][Full Text] [Related]
12. Results of phase I-II trial of concomitant hyperfractionated radiation and oral etoposide (VP-16) in patients with unresectable squamous cell carcinoma of the head and neck. Khafif A; Canfield VA; Syzek EJ; Medina JE Am J Otolaryngol; 2003; 24(1):1-5. PubMed ID: 12579475 [TBL] [Abstract][Full Text] [Related]
13. Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinoma. Lavaf A; Genden EM; Cesaretti JA; Packer S; Kao J Cancer; 2008 Feb; 112(3):535-43. PubMed ID: 18076014 [TBL] [Abstract][Full Text] [Related]
14. Altered fractionation and/or adjuvant chemotherapy in definitive irradiation of squamous cell carcinoma of the head and neck. Mendenhall WM; Riggs CE; Amdur RJ; Hinerman RW; Villaret DB Laryngoscope; 2003 Mar; 113(3):546-51. PubMed ID: 12616212 [TBL] [Abstract][Full Text] [Related]
15. Bioreductive alkylating agent porfiromycin in combination with radiation therapy for the management of squamous cell carcinoma of the head and neck. Haffty BG; Son YH; Wilson LD; Papac R; Fischer D; Rockwell S; Sartorelli AC; Ross D; Sasaki CT; Fischer JJ Radiat Oncol Investig; 1997; 5(5):235-45. PubMed ID: 9372546 [TBL] [Abstract][Full Text] [Related]
16. Alteration of radiotherapy fractionation and concurrent chemotherapy: a new frontier in head and neck oncology? Bernier J Nat Clin Pract Oncol; 2005 Jun; 2(6):305-14. PubMed ID: 16264988 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of prognostic factors and two radiation techniques in patients treated with surgery followed by radio(chemo)therapy or definitive radio(chemo)therapy for locally advanced head-and-neck cancer. Rades D; Stoehr M; Meyners T; Bohlen G; Nadrowitz R; Dunst J; Schild SE; Wroblewski J; Albers D; Schmidt R; Alberti W; Tribius S Strahlenther Onkol; 2008 Apr; 184(4):198-205. PubMed ID: 18398584 [TBL] [Abstract][Full Text] [Related]
18. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Bernier J; Cooper JS; Pajak TF; van Glabbeke M; Bourhis J; Forastiere A; Ozsahin EM; Jacobs JR; Jassem J; Ang KK; Lefèbvre JL Head Neck; 2005 Oct; 27(10):843-50. PubMed ID: 16161069 [TBL] [Abstract][Full Text] [Related]
19. Radiotherapeutic management of locally advanced head and neck cancer. Laskar SG; Agarwal JP; Srinivas C; Dinshaw KA Expert Rev Anticancer Ther; 2006 Mar; 6(3):405-17. PubMed ID: 16503857 [TBL] [Abstract][Full Text] [Related]
20. Hypofractionated radiotherapy denoted as the "Christie scheme": an effective means of palliating patients with head and neck cancers not suitable for curative treatment. Al-mamgani A; Tans L; Van rooij PH; Noever I; Baatenburg de jong RJ; Levendag PC Acta Oncol; 2009; 48(4):562-70. PubMed ID: 19373698 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]